|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105 TWD | +0.96% |
|
-3.67% | -42.78% |
Handa Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 217.37 million compared to TWD 331.23 million a year ago. Net income was TWD 117.09 million compared to TWD 246.85 million a year ago.
Basic earnings per share from continuing operations was TWD 0.83 compared to TWD 1.9 a year ago. Diluted earnings per share from continuing operations was TWD 0.83 compared to TWD 1.89 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.78% | 450M | |
| +20.39% | 43.67B | |
| +26.21% | 22.79B | |
| +21.43% | 15.45B | |
| +18.82% | 14.29B | |
| +53.37% | 12.83B | |
| -0.05% | 6.79B | |
| -11.88% | 6.52B | |
| -8.87% | 5.73B | |
| +12.62% | 5.59B |
HANDA PHARMACEUTICALS, INC. 
